UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 340

Sortiert nach

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

Cancer and metastasis reviews, 2020-12, Vol.39 (4), p.1029-1038

2020

Link zum Volltext

Verfügbarkeit prüfen

Guest editorial/preface

Cancer and metastasis reviews, 2020-12, Vol.39 (4), p.1017-1017

Tímár, József

2020

Link zum Volltext

Verfügbarkeit prüfen

The clinical relevance of KRAS gene mutation in non-small-cell lung cancer

Current opinion in oncology, 2014-03, Vol.26 (2), p.138-144

Tímár, József

2014

Link zum Volltext

Verfügbarkeit prüfen

On-Target Side Effects of Targeted Therapeutics of Cancer

Pathology oncology research, 2022-09, Vol.28, p.1610694-1610694

2022

Link zum Volltext

Verfügbarkeit prüfen

KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges

Pathology oncology research, 2024-01, Vol.29, p.1611580-1611580

2024

Link zum Volltext

Verfügbarkeit prüfen

Immunologic and immunogenomic aspects of tumor progression

Seminars in cancer biology, 2020-02, Vol.60, p.249-261

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic evolution during tumor progression: from basic research to clinical practice

Cancer and metastasis reviews, 2016-03, Vol.35 (1), p.3-4

Tímár, József

2016

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Pathology oncology research, 2021-05, Vol.27, p.1609802-1609802

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of B-cell density in cutaneous melanoma

Cancer Immunology, Immunotherapy, 2011-12, Vol.60 (12), p.1729-1738

2011

Link zum Volltext

Verfügbarkeit prüfen

Metastatic Progression of Human Melanoma

Cancers, 2023-02, Vol.15 (4), p.1225

2023

Link zum Volltext

Verfügbarkeit prüfen

Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development

International journal of molecular sciences, 2024-03, Vol.25 (5), p.2572

2024

Link zum Volltext

Verfügbarkeit prüfen

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1025-1034

2012

Link zum Volltext

Verfügbarkeit prüfen

Editorial: Pathology and Oncology Research: addressing publication ethics issues

Pathology oncology research, 2024, Vol.30, p.1611691-1611691

2024

Link zum Volltext

Verfügbarkeit prüfen

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner

PloS one, 2017-11, Vol.12 (11), p.e0187094-e0187094

2017

Link zum Volltext

Verfügbarkeit prüfen

The role of lipid signaling in the progression of malignant melanoma

Cancer and metastasis reviews, 2018-09, Vol.37 (2-3), p.245-255

2018

Link zum Volltext

Verfügbarkeit prüfen

Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging

Analytical and bioanalytical chemistry, 2012-06, Vol.403 (8), p.2315-2325

2012

Link zum Volltext

Verfügbarkeit prüfen

Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells

BMC cancer, 2018-10, Vol.18 (1), p.1029-1029, Article 1029

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series

Journal of translational medicine, 2024-02, Vol.22 (1), p.150-150

2024

Link zum Volltext

Verfügbarkeit prüfen

Alternative Vascularization Mechanisms in Cancer: Pathology and Therapeutic Implications

The American journal of pathology, 2007-01, Vol.170 (1), p.1-15

2007

Link zum Volltext

Verfügbarkeit prüfen

Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors

British journal of cancer, 2024-04, Vol.130 (6), p.1059-1072

2024

Link zum Volltext

Verfügbarkeit prüfen

Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?

Pathology oncology research, 2024, Vol.30, p.1611719-1611719

2024

Link zum Volltext

Verfügbarkeit prüfen

Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations

International journal of molecular sciences, 2020-10, Vol.21 (20), p.7649

2020

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

Journal of cancer research and clinical oncology, 2018-07, Vol.144 (7), p.1219-1226

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas

Oral oncology, 2011-06, Vol.47 (6), p.487-496

2011

Link zum Volltext

Verfügbarkeit prüfen

Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry

Cancer and metastasis reviews, 2023-03, Vol.42 (1), p.323-334

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 340

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(314)
Mit Volltextzugriff
(280)

Publikationsform

Artikel
(340)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

Guest editorial/preface

The clinical relevance of KRAS gene mutation in non-small-cell lung cancer

On-Target Side Effects of Targeted Therapeutics of Cancer

KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges

Immunologic and immunogenomic aspects of tumor progression

Genetic evolution during tumor progression: from basic research to clinical practice

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Prognostic impact of B-cell density in cutaneous melanoma

Metastatic Progression of Human Melanoma

Gluing GAP to RAS Mutants: A New Approach to an Old Problem in Cancer Drug Development

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data

Editorial: Pathology and Oncology Research: addressing publication ethics issues

The phosphomimetic mutation of syndecan-4 binds and inhibits Tiam1 modulating Rac1 activity in PDZ interaction-dependent manner

The role of lipid signaling in the progression of malignant melanoma

Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging

Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells

Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series

Alternative Vascularization Mechanisms in Cancer: Pathology and Therapeutic Implications

Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors

Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?

Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations

Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas

Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry

Suchergebnisse filtern